期刊文献+

急性白血病化疗后医院感染及抗感染治疗分析 被引量:22

Analysis of nosocomial infection in acute leukemia patients after chemotherapy and antibiotic therapy
下载PDF
导出
摘要 目的:探讨急性白血病(AL)化疗后医院感染(HAI)的易感因素、防治方法及预防措施。方法:对93例初治AL患者住院化疗后的医院感染发生及治疗情况进行回顾性分析。结果:中性粒细胞计数(ANC)降低、年龄>60岁、未能完全缓解(CR)患者医院感染率增高,抗生素联合粒细胞集落刺激因子(G-CSF)治疗使化疗后AL患者发热及ANC恢复天数分别缩短为(7.0±1.89)d和(6.0±1.3)d。结论:AL患者化疗后ANC降低、患者年龄>60岁及未获得CR是医院感染主要易感因素,抗生素加用G-CSF合理应用,能减少医院感染发生率及严重程度。 Objective:To investigate the risk factors of nosocomial infection after chemotherapy in acute leukemia patients, and discuss the methods of prevention and treatmeat. Method:Ninety-three nosocomial infection cases and their therapy were analyzed retrospectively in acute leukemia patients who had chemotherapy. Result: The infection rate of the patients whose age exceeded 60, had lower absolute neutrophil count (ANC) and didnot reach complete remission were higher. Combining antibiotic therapy and GSF shortened the days of fever and recover of ANC to 7.00±1.8, 9.8±2.0, days respectively. Conclusion:The lowl ANC and old ages of the patients are the primary risk factors that lead to nosocomial infection; Combining antibiotic therapy and GSF could reduced the nosocomial infection rate and its seriousness.
出处 《临床血液学杂志》 CAS 2007年第6期339-340,343,共3页 Journal of Clinical Hematology
关键词 白血病 急性 医院感染 治疗 Acute leukemia Nosocomial infection Therapy
  • 相关文献

参考文献9

二级参考文献32

  • 1顾伟英,谢晓宝,曹祥山,华铮,华晓莹.急性白血病患者化疗后合并败血症临床分析[J].临床荟萃,2004,19(14):801-802. 被引量:11
  • 2吴安华,任南,文细毛,易霞云,黄勋,徐秀华.159所医院医院感染现患率调查结果与分析[J].中国感染控制杂志,2005,4(1):12-16. 被引量:202
  • 3刘利,刘思纯.白血病患者医院感染的临床分析[J].白血病,1996,5(3):164-165. 被引量:28
  • 4卫生部医政司医院内感染监控小组.医院内感染的诊断标准[J].中华医院管理杂志,1990,5:306-306. 被引量:20
  • 5Tenssaie Z W. Multiple antimicrobial resistance in gram-negative bacilii isolated from clinical specimen,Jimma Hospital, southwest Ethiopia. Ethiop Med J,2001, 39:305-312. 被引量:1
  • 6Cornely O A, Ullmann A J, Karthaus M. Antifungal prosphylaxis in neutropenic patients. Wien Med Wochenschr, 2001, 151:73-79. 被引量:1
  • 7Sypula W T, Kale-Pradhan P B. Therapeutic dilemma of fluconazole prophylaxis in intensive care. Ann Phar macother, 2002, 36;155-159. 被引量:1
  • 8Lyman G H, Kuderer N M, Djulbegovic B, Prophylactic granulocyte colony-stimulating factor in patients receiving dose-intensive cancer chemotherapy: a meta-analysis. Am J Med, 2002, 113:766-768. 被引量:1
  • 9Hughes WT,Armstrong D,Bodey GP,et al.2002 guidelines for the use of antimicrobial agents in the neutropenic patients with cancer.CID,2002,34:730-751 被引量:1
  • 10Funai N.Ten-year survey of incidence of infection as a cause of death in hematologic malignancies:study of 90 autopsied cases.Acta Haemetol,1995,93:25-28 被引量:1

共引文献78

同被引文献169

引证文献22

二级引证文献118

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部